ID   ENTP1_HUMAN             Reviewed;         510 AA.
AC   P49961; A9Z1X8; B4DWB9; B4E1X1; B7Z599; G3XAF6; Q5T561; Q5T562;
AC   Q86VV3; Q9UQQ9; Q9Y3Q9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Ectonucleoside triphosphate diphosphohydrolase 1;
DE            Short=NTPDase 1;
DE            EC=3.6.1.5;
DE   AltName: Full=Ecto-ATP diphosphohydrolase 1;
DE            Short=Ecto-ATPDase 1;
DE            Short=Ecto-ATPase 1;
DE   AltName: Full=Ecto-apyrase;
DE   AltName: Full=Lymphoid cell activation antigen;
DE   AltName: CD_antigen=CD39;
GN   Name=ENTPD1; Synonyms=CD39;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7930580;
RA   Maliszewski C.R., Delespesse G.J.T., Schoenborn M.A., Armitage R.J.,
RA   Fanslow W.C., Nakajima T., Baker E., Sutherland G.R., Poindexter K.,
RA   Birks C., Alpert A., Friend D., Gimpel S.D., Gayle R.B. III;
RT   "The CD39 lymphoid cell activation antigen. Molecular cloning and
RT   structural characterization.";
RL   J. Immunol. 153:3574-3583(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical vein;
RX   PubMed=8996251; DOI=10.1084/jem.185.1.153;
RA   Robson S.C., Kaczmarek E., Siegel J.B., Candinas D., Koziak K.,
RA   Millan M., Hancock W.W., Bach F.H.;
RT   "Loss of ATP diphosphohydrolase activity with endothelial cell
RT   activation.";
RL   J. Exp. Med. 185:153-163(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=10405171; DOI=10.1016/S0014-5793(99)00751-6;
RA   Matsumoto M., Sakurai Y., Kokubo T., Yagi H., Makita K., Matsui T.,
RA   Titani K., Fujimura Y., Narita N.;
RT   "The cDNA cloning of human placental ecto-ATP diphosphohydrolases I
RT   and II.";
RL   FEBS Lett. 453:335-340(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4; 5 AND 6).
RC   TISSUE=Brain, Synovium, Trachea, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 240-242; 162-166; 185-189; 210-223; 243-249 AND
RP   288-297.
RC   TISSUE=Placenta;
RX   PubMed=8529670; DOI=10.1111/j.1432-1033.1995.066_c.x;
RA   Christoforidis S., Papamarcaki T., Galaris D., Kellner R., Tsolas O.;
RT   "Purification and properties of human placental ATP
RT   diphosphohydrolase.";
RL   Eur. J. Biochem. 234:66-74(1995).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-30; 49-65; 94-97; 88-93; 193-223; 245-265;
RP   382-385 AND 399-405 (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=9846014; DOI=10.1016/S0925-5710(98)00080-2;
RA   Makita K., Shimoyama T., Sakurai Y., Yagi H., Matsumoto M., Narita N.,
RA   Sakamoto Y., Saito S., Ikeda Y., Suzuki M., Titani K., Fujimura Y.;
RT   "Placental ecto-ATP diphosphohydrolase: its structural feature
RT   distinct from CD39, localization and inhibition on shear-induced
RT   platelet aggregation.";
RL   Int. J. Hematol. 68:297-310(1998).
RN   [10]
RP   FUNCTION, AND COFACTOR.
RX   PubMed=8955160; DOI=10.1074/jbc.271.51.33116;
RA   Kaczmarek E., Koziak K., Sevigny J., Siegel J.B., Anrather J.,
RA   Beaudoin A.R., Bach F.H., Robson S.C.;
RT   "Identification and characterization of CD39/vascular ATP
RT   diphosphohydrolase.";
RL   J. Biol. Chem. 271:33116-33122(1996).
RN   [11]
RP   CHARACTERIZATION.
RX   PubMed=8626624; DOI=10.1074/jbc.271.17.10391;
RA   Wang T.F., Guidotti G.;
RT   "CD39 is an ecto-(Ca2+,Mg2+)-apyrase.";
RL   J. Biol. Chem. 271:9898-9901(1996).
RN   [12]
RP   PALMITOYLATION AT CYS-13.
RX   PubMed=10636909; DOI=10.1074/jbc.275.3.2057;
RA   Koziak K., Kaczmarek E., Kittel A., Sevigny J., Blusztajn J.K.,
RA   Schulte Am Esch J. II, Imai M., Guckelberger O., Goepfert C., Qawi I.,
RA   Robson S.C.;
RT   "Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to
RT   caveolae.";
RL   J. Biol. Chem. 275:2057-2062(2000).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-73 AND ASN-292.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   VARIANT SPG64 ARG-210.
RX   PubMed=24482476; DOI=10.1126/science.1247363;
RA   Novarino G., Fenstermaker A.G., Zaki M.S., Hofree M., Silhavy J.L.,
RA   Heiberg A.D., Abdellateef M., Rosti B., Scott E., Mansour L.,
RA   Masri A., Kayserili H., Al-Aama J.Y., Abdel-Salam G.M., Karminejad A.,
RA   Kara M., Kara B., Bozorgmehri B., Ben-Omran T., Mojahedi F.,
RA   Mahmoud I.G., Bouslam N., Bouhouche A., Benomar A., Hanein S.,
RA   Raymond L., Forlani S., Mascaro M., Selim L., Shehata N.,
RA   Al-Allawi N., Bindu P.S., Azam M., Gunel M., Caglayan A., Bilguvar K.,
RA   Tolun A., Issa M.Y., Schroth J., Spencer E.G., Rosti R.O., Akizu N.,
RA   Vaux K.K., Johansen A., Koh A.A., Megahed H., Durr A., Brice A.,
RA   Stevanin G., Gabriel S.B., Ideker T., Gleeson J.G.;
RT   "Exome sequencing links corticospinal motor neuron disease to common
RT   neurodegenerative disorders.";
RL   Science 343:506-511(2014).
CC   -!- FUNCTION: In the nervous system, could hydrolyze ATP and other
CC       nucleotides to regulate purinergic neurotransmission. Could also
CC       be implicated in the prevention of platelet aggregation by
CC       hydrolyzing platelet-activating ADP to AMP. Hydrolyzes ATP and ADP
CC       equally well. {ECO:0000269|PubMed:8955160}.
CC   -!- CATALYTIC ACTIVITY: A nucleoside 5'-triphosphate + 2 H(2)O = a
CC       nucleoside 5'-phosphate + 2 phosphate.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:8955160};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:8955160};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.0-7.5 with ATP as substrate, and 7.5-8.0 with
CC         ADP as substrate.;
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q96S59:RANBP9; NbExp=5; IntAct=EBI-8074749, EBI-636085;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=Vascular;
CC         IsoId=P49961-1; Sequence=Displayed;
CC       Name=2; Synonyms=Placental I;
CC         IsoId=P49961-2; Sequence=VSP_003607;
CC       Name=3; Synonyms=Placental II;
CC         IsoId=P49961-3; Sequence=VSP_003607, VSP_003608, VSP_003609;
CC       Name=4;
CC         IsoId=P49961-4; Sequence=VSP_044284;
CC       Name=5;
CC         IsoId=P49961-5; Sequence=VSP_044283;
CC       Name=6;
CC         IsoId=P49961-6; Sequence=VSP_046050;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed primarily on activated lymphoid
CC       cells. Also expressed in endothelial tissues. Isoform 1 and
CC       isoform 3 are present in both placenta and umbilical vein, whereas
CC       isoform 2 is present in placenta only.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Palmitoylated in the N-terminal part.
CC       {ECO:0000269|PubMed:10636909}.
CC   -!- DISEASE: Spastic paraplegia 64, autosomal recessive (SPG64)
CC       [MIM:615683]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness
CC       and spasticity of the lower limbs. Rate of progression and the
CC       severity of symptoms are quite variable. Initial symptoms may
CC       include difficulty with balance, weakness and stiffness in the
CC       legs, muscle spasms, and dragging the toes when walking. In some
CC       forms of the disorder, bladder symptoms (such as incontinence) may
CC       appear, or the weakness and stiffness may spread to other parts of
CC       the body. {ECO:0000269|PubMed:24482476}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the GDA1/CD39 NTPase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S73813; AAB32152.1; -; mRNA.
DR   EMBL; U87967; AAB47572.1; -; mRNA.
DR   EMBL; AK304836; BAG65580.1; -; mRNA.
DR   EMBL; AJ133133; CAB41886.1; -; mRNA.
DR   EMBL; AJ133134; CAB41887.1; -; mRNA.
DR   EMBL; AK298648; BAH12835.1; -; mRNA.
DR   EMBL; AK301459; BAG62981.1; -; mRNA.
DR   EMBL; AK304018; BAG64933.1; -; mRNA.
DR   EMBL; AK316009; BAH14380.1; -; mRNA.
DR   EMBL; AL356632; CAI16771.1; -; Genomic_DNA.
DR   EMBL; AL365273; CAI16771.1; JOINED; Genomic_DNA.
DR   EMBL; AL365273; CAH73752.1; -; Genomic_DNA.
DR   EMBL; AL365273; CAH73753.1; -; Genomic_DNA.
DR   EMBL; AL356632; CAH73753.1; JOINED; Genomic_DNA.
DR   EMBL; AL365273; CAH73754.1; -; Genomic_DNA.
DR   EMBL; AL356632; CAH73754.1; JOINED; Genomic_DNA.
DR   EMBL; AL356632; CAI16770.1; -; Genomic_DNA.
DR   EMBL; AL365273; CAI16770.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW49988.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49989.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49990.1; -; Genomic_DNA.
DR   EMBL; BC047664; AAH47664.1; -; mRNA.
DR   CCDS; CCDS41554.1; -. [P49961-2]
DR   CCDS; CCDS53556.1; -. [P49961-6]
DR   CCDS; CCDS53557.1; -. [P49961-5]
DR   CCDS; CCDS53558.1; -. [P49961-4]
DR   CCDS; CCDS7444.1; -. [P49961-1]
DR   PIR; I56242; I56242.
DR   RefSeq; NP_001091645.1; NM_001098175.1. [P49961-2]
DR   RefSeq; NP_001157650.1; NM_001164178.1. [P49961-6]
DR   RefSeq; NP_001157653.1; NM_001164181.1. [P49961-5]
DR   RefSeq; NP_001157654.1; NM_001164182.1. [P49961-4]
DR   RefSeq; NP_001157655.1; NM_001164183.1. [P49961-4]
DR   RefSeq; NP_001299583.1; NM_001312654.1. [P49961-5]
DR   RefSeq; NP_001307845.1; NM_001320916.1.
DR   RefSeq; NP_001767.3; NM_001776.5. [P49961-1]
DR   RefSeq; XP_011538673.1; XM_011540371.2. [P49961-2]
DR   RefSeq; XP_011538679.1; XM_011540377.2. [P49961-5]
DR   RefSeq; XP_016872448.1; XM_017016959.1. [P49961-4]
DR   UniGene; Hs.576612; -.
DR   UniGene; Hs.722260; -.
DR   ProteinModelPortal; P49961; -.
DR   SMR; P49961; -.
DR   BioGrid; 107391; 1.
DR   IntAct; P49961; 1.
DR   MINT; MINT-8215689; -.
DR   STRING; 9606.ENSP00000360250; -.
DR   BindingDB; P49961; -.
DR   ChEMBL; CHEMBL5722; -.
DR   GuidetoPHARMACOLOGY; 2888; -.
DR   iPTMnet; P49961; -.
DR   PhosphoSitePlus; P49961; -.
DR   SwissPalm; P49961; -.
DR   BioMuta; ENTPD1; -.
DR   DMDM; 1705710; -.
DR   MaxQB; P49961; -.
DR   PaxDb; P49961; -.
DR   PeptideAtlas; P49961; -.
DR   PRIDE; P49961; -.
DR   DNASU; 953; -.
DR   Ensembl; ENST00000371205; ENSP00000360248; ENSG00000138185. [P49961-1]
DR   Ensembl; ENST00000371207; ENSP00000360250; ENSG00000138185. [P49961-6]
DR   Ensembl; ENST00000453258; ENSP00000390955; ENSG00000138185. [P49961-2]
DR   Ensembl; ENST00000543964; ENSP00000442968; ENSG00000138185. [P49961-5]
DR   GeneID; 953; -.
DR   KEGG; hsa:953; -.
DR   UCSC; uc001klh.5; human. [P49961-1]
DR   CTD; 953; -.
DR   DisGeNET; 953; -.
DR   GeneCards; ENTPD1; -.
DR   HGNC; HGNC:3363; ENTPD1.
DR   HPA; CAB002494; -.
DR   HPA; HPA014067; -.
DR   MalaCards; ENTPD1; -.
DR   MIM; 601752; gene.
DR   MIM; 615683; phenotype.
DR   neXtProt; NX_P49961; -.
DR   OpenTargets; ENSG00000138185; -.
DR   Orphanet; 401810; Autosomal recessive spastic paraplegia type 64.
DR   PharmGKB; PA27798; -.
DR   eggNOG; KOG1386; Eukaryota.
DR   eggNOG; COG5371; LUCA.
DR   GeneTree; ENSGT00550000074435; -.
DR   HOGENOM; HOG000059572; -.
DR   HOVERGEN; HBG018982; -.
DR   InParanoid; P49961; -.
DR   KO; K01510; -.
DR   OMA; PSYFWKE; -.
DR   OrthoDB; EOG091G05FZ; -.
DR   PhylomeDB; P49961; -.
DR   TreeFam; TF332859; -.
DR   BioCyc; MetaCyc:HS06471-MONOMER; -.
DR   Reactome; R-HSA-8850843; Phosphate bond hydrolysis by NTPDase proteins.
DR   ChiTaRS; ENTPD1; human.
DR   GeneWiki; ENTPD1; -.
DR   GenomeRNAi; 953; -.
DR   PRO; PR:P49961; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000138185; -.
DR   CleanEx; HS_ENTPD1; -.
DR   ExpressionAtlas; P49961; baseline and differential.
DR   Genevisible; P49961; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0102490; F:8-oxo-dGTP phosphohydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017110; F:nucleoside-diphosphatase activity; EXP:Reactome.
DR   GO; GO:0017111; F:nucleoside-triphosphatase activity; EXP:Reactome.
DR   GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; NAS:ProtInc.
DR   GO; GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome.
DR   InterPro; IPR000407; GDA1_CD39_NTPase.
DR   PANTHER; PTHR11782; PTHR11782; 1.
DR   Pfam; PF01150; GDA1_CD39; 1.
DR   PROSITE; PS01238; GDA1_CD39_NTPASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Hereditary spastic paraplegia; Hydrolase; Lipoprotein;
KW   Magnesium; Membrane; Neurodegeneration; Nucleotide-binding; Palmitate;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    510       Ectonucleoside triphosphate
FT                                diphosphohydrolase 1.
FT                                /FTId=PRO_0000209902.
FT   TOPO_DOM      1     16       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     17     37       Helical. {ECO:0000255}.
FT   TOPO_DOM     38    478       Extracellular. {ECO:0000255}.
FT   TRANSMEM    479    499       Helical. {ECO:0000255}.
FT   TOPO_DOM    500    510       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    174    174       Proton acceptor. {ECO:0000250}.
FT   LIPID        13     13       S-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:10636909}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    227    227       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    334    334       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    371    371       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    457    457       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     84    108       {ECO:0000250}.
FT   DISULFID    255    301       {ECO:0000250}.
FT   DISULFID    282    325       {ECO:0000250}.
FT   DISULFID    338    343       {ECO:0000250}.
FT   DISULFID    390    413       {ECO:0000250}.
FT   VAR_SEQ       1    138       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044284.
FT   VAR_SEQ       1    108       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044283.
FT   VAR_SEQ       1      5       MEDTK -> MGREELFLTFSFSSGFQ (in isoform
FT                                6). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046050.
FT   VAR_SEQ       1      4       MEDT -> MKGTKDLTSQQ (in isoform 2 and
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:10405171}.
FT                                /FTId=VSP_003607.
FT   VAR_SEQ     272    299       VASNEILRDPCFHPGYKKVVNVSDLYKT -> ASITQSRPA
FT                                PFTSAPPAPTSCCFLFQIQ (in isoform 3).
FT                                {ECO:0000303|PubMed:10405171}.
FT                                /FTId=VSP_003608.
FT   VAR_SEQ     300    510       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10405171}.
FT                                /FTId=VSP_003609.
FT   VARIANT     210    210       G -> R (in SPG64).
FT                                {ECO:0000269|PubMed:24482476}.
FT                                /FTId=VAR_071082.
FT   VARIANT     293    293       V -> I (in dbSNP:rs3793744).
FT                                /FTId=VAR_022099.
FT   CONFLICT     57     58       SS -> G (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    162    162       D -> K (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    208    208       T -> TGET (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    248    248       V -> Y (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    481    481       M -> I (in Ref. 4; BAG62981).
FT                                {ECO:0000305}.
SQ   SEQUENCE   510 AA;  57965 MW;  BAD87D2499649159 CRC64;
     MEDTKESNVK TFCSKNILAI LGFSSIIAVI ALLAVGLTQN KALPENVKYG IVLDAGSSHT
     SLYIYKWPAE KENDTGVVHQ VEECRVKGPG ISKFVQKVNE IGIYLTDCME RAREVIPRSQ
     HQETPVYLGA TAGMRLLRME SEELADRVLD VVERSLSNYP FDFQGARIIT GQEEGAYGWI
     TINYLLGKFS QKTRWFSIVP YETNNQETFG ALDLGGASTQ VTFVPQNQTI ESPDNALQFR
     LYGKDYNVYT HSFLCYGKDQ ALWQKLAKDI QVASNEILRD PCFHPGYKKV VNVSDLYKTP
     CTKRFEMTLP FQQFEIQGIG NYQQCHQSIL ELFNTSYCPY SQCAFNGIFL PPLQGDFGAF
     SAFYFVMKFL NLTSEKVSQE KVTEMMKKFC AQPWEEIKTS YAGVKEKYLS EYCFSGTYIL
     SLLLQGYHFT ADSWEHIHFI GKIQGSDAGW TLGYMLNLTN MIPAEQPLST PLSHSTYVFL
     MVLFSLVLFT VAIIGLLIFH KPSYFWKDMV
//
